Actively Recruiting
The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis
Led by Cheng, yu-ting · Updated on 2025-03-20
112
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.
CONDITIONS
Official Title
The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with ocular myasthenia by a doctor
- Currently taking oral Mestinon (Pyridostigmine Bromide) as prescribed by a Western medicine doctor
- Patients aged 20 years and older
- Able to understand and speak Mandarin or Taiwanese
- Clear consciousness with no diagnosed mental illness
- Patients and their families willing to receive integrated traditional Chinese and Western medicine treatment
You will not qualify if you...
- Patients with liver failure or kidney failure
- Allergy symptoms to traditional Chinese medicine, such as skin itching and redness
- Patients with malignant tumors
- Patients currently undergoing radiotherapy or chemotherapy
- Pregnant women
- Patients with implanted cardiac rhythm devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
Y
yuting Cheng
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here